×
English
हिंदी
ગુજરાતી
Home
My Feed
Remove Ads
Get Premium Content
Go Pro @₹99
Loan Against Mutual Fund
Apply Now
Credit Cards
Instant Loans
Apply Now
Credit Score
Refer & Earn ₹500
Refer Now
Finance Tracker
Learning Curve
Fixed Deposits
Business Loan
Vouchers
Markets
Markets
FII & DII Activity
Corporate Action
Research Advice
Earnings
Technical Trends
Stock Deals
Intraday Large Deals
Bonds
Webinar
Pre Market
Stock Scanner
Sector Analysis
Unlisted Shares
Stock Updates
PRO Stock Lists
Monsoon Tracker
Seasonality Analysis
Crypto Dashboard
Web Stories
Tax Calculator
Forum
Gold Rate
Silver Rate
IFSC Code Finder
Storyboard18
IPO
Economic Indicators
Economic Calendar
Global Markets
US Markets
ETFs
Indian Indices
News
News
Tech/Startups
Auto
Research
Opinion
Politics
Personal Finance
EPF Guide
Real Estate
Portfolio
Watchlist
Personal Finance
Personal Finance
Loans
Fixed Deposit Comparison
Fixed Deposit Interest Calculator
Moneycontrol - SecureNow Health Insurance ratings
Mutual Funds
Mutual Funds
Performance Tracker
Top ranked funds
My Portfolio
Top performing Categories
Forum
New Fund Offers
MF Simplified
Commodities
Mutual Funds
Gold Rate
Silver Rate
Currencies
Cryptocurrency
Media
Live TV & Shows
Video
Podcast
Photos
Invest Now
Trade like Experts
Invest in Unlisted Shares
Specials
Pharma Industry Conclave
Unlocking opportunities in Metal and Mining
#MFSummit2025
Advanced Technical Charts
International
Get App
Be a
Pro
Home
PRO
Markets
News
Budget 2026
Editor’s Picks
Tech
India
Learning Curve
Portfolio
Watchlist
Commodities
MF
PF
Forum
Videos
you are here:
Home
News
Alembic Pharmaceuticals
Alembic Pharmaceuticals
Alembic Pharma shares gain 2% on USFDA nod for Diltiazem Hydrochloride tablets
Stocks to Watch Today: Lupin, Narayana Hrudayala, V2 Retail, Websol, TruAlt Bioenergy, IRB Infra, Alembic Pharma, Max Healthcare in focus on 17 November
Alembic Pharma Standalone September 2025 Net Sales at Rs 1,796.24 crore, up 13.66% Y-o-Y
Alembic Pharma Consolidated September 2025 Net Sales at Rs 1,910.15 crore, up 15.91% Y-o-Y
Stocks to Watch Today: Reliance Ind, RBL Bank, IRB Infra, ICICI Bank, HDFC Bank, IRCON, Sterling & Wilson, RVNL, UltraTech, IDBI, Sobha in focus on 20 October
Alembic Pharma shares gain on EIR from USFDA for Panelav unit
Stocks to Watch Today: Apollo Hospitals, Dr Reddys Labs, Tata Tech, Shakti Pumps, Alembic Pharma, Diamond Power, EIL, RailTel, Adani Power, Ceigall in focus on 15 September
Stocks to Watch Today: Glenmark, Inox Wind, Zaggle, Easy Trip, KEC International, EMS, Torrent Power, JK Cement, Globe Civil, Indian Bank in focus on 18 August
Alembic Pharma Consolidated June 2025 Net Sales at Rs 1,710.72 crore, up 9.54% Y-o-Y
Alembic Pharma Standalone June 2025 Net Sales at Rs 1,494.17 crore, up 1.26% Y-o-Y
Alembic Pharmaceuticals shares gain on final approval for anticonvulsant drug
Stocks to Watch Today: Kotak Bank, CDSL, Balkrishna Ind, Orient Cement, Tata Chemicals, Poonawalla Fincorp, VA Tech Wabag, RITES in focus on 28 July
Alembic Pharma shares gain 10% on USFDA approval for Doxorubicin Hydrochloride Injection
Stocks to Watch Today: Urgo Capital, Delhivery, SML Isuzu, Hindustan Zinc, Bharat Forge, Polycab, RailTel Corporation in focus on 18 June
Alembic Pharma shares fall post USFDA issues 4 observations for Panelav facility
Stocks to Watch Today: Tata Motors, M&M, Niva Bupa, Alembic Pharma, IRCON, Godrej Properties, Titagarh, AstraZeneca, Genus Power, Nykaa in focus on 2 June
Alembic Pharma Consolidated March 2025 Net Sales at Rs 1,769.64 crore, up 16.66% Y-o-Y
Alembic Pharma Standalone March 2025 Net Sales at Rs 1,570.64 crore, up 6.52% Y-o-Y
Stocks to Watch Today: Bajaj Finance, IndusInd Bank, IndiaMART, Schaeffler India, Vishal Mega Mart, Prestige Estates, Strides Pharma in focus on 30 April
Stocks to Watch Today: Welspun Corp, NCC, Mahindra and Mahindra, Dr Reddys, Alembic Pharma, Godrej Properties, DAM Capital in focus on 24 March
Stocks to Watch Today: IndusInd Bank, HUL, Bank of Maharashtra, IRCON, Star Cement, Raymond Lifestyle, Shilpa Medicare, NBCC in focus on 18 March
Stocks to Watch Today: Lupin, Tata Power, Nazara Tech, Shilpa Medicare, GMR Airports, IRB Infra, Railtel, Shyam Metalics in focus on 10 March
Stocks to Watch Today: Alembic Pharma, BHEL, Zydus Life, Zen Technologies, Ajax Engineering, Utkarsh SFB, Glenmark in focus on 17 February
Alembic Pharma Consolidated December 2024 Net Sales at Rs 1,692.74 crore, up 3.81% Y-o-Y
Alembic Pharma Standalone December 2024 Net Sales at Rs 1,406.09 crore, down 11.48% Y-o-Y
View More
Home
Markets
Loans
SPIN
2
WIN
News
Portfolio